e-Therapeutics (ETX)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

37.25p
   
  • Change Today:
      0.75p
  • 52 Week High: 44.00
  • 52 Week Low: 25.25
  • Currency: UK Pounds
  • Shares Issued: 13.13m
  • Volume: 44,056
  • Market Cap: £4.89m

Latest ShareCast News

Bramson vehicle buys more shares in F&C

Date: Tuesday 15 Mar 2011

A round-up of the biggest director deals today so far.

e-Therapeutics ShareCast News

Wife of outgoing FD sells British Land shares 14-Mar-2011 ShareCast
Shaftesbury boss invests £100,000 04-Mar-2011 ShareCast
Small caps round-up: Northern Bear, Airsprung, P... 29-Jun-2010 ShareCast
Chairman's wife buys Redrow shares 02-Mar-2010 ShareCast
e-Therapeutics narrows losses 27-Jul-2009 ShareCast

e-Therapeutics Regulatory News

e-Therapeutics' Preliminary Results for the Year... 22-May-2012 07:03 Business Wire
Notice of Results 10-May-2012 07:00 RNS
Director/PDMR Shareholding 04-May-2012 18:00 RNS
Change of Registered Office 17-Apr-2012 15:55 RNS
Phase I clinical trials of cancer drug ETS2101 a... 29-Mar-2012 07:00 Business Wire

e-Therapeutics Newspaper Links

No recent information was found.

e-Therapeutics Tips & Analysis

Market Report: A&L buoyed by talk of Santander b... 29-Nov-2007 The Independent

e-Therapeutics News Wires

No recent information was found.

Other e-Therapeutics News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 37.25p
Change Today 0.75p
% Change 2.05 %
52 Week High 44.00
52 Week Low 25.25
Volume 44,056
Shares Issued 13.13m
Market Cap £4.89m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.30% above the market average47.30% above the market average47.30% above the market average47.30% above the market average47.30% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Price Trend
60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average60.98% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

e-Therapeutics Dividends

No dividends found

Trades for 31-May-2012

Time Volume / Share Price
16:18 854 @ 37.80p
12:48 217 @ 37.80p
11:23 1,157 @ 36.50p
11:11 7,500 @ 37.75p
09:08 10,000 @ 37.35p

e-Therapeutics Key Personnel

CEO Professor Malcolm Young
CFO Daniel Elger

Top of Page